Fjærestad Tobias, Øyrås Petter, Solbakk Knut Inge, Leonardsen Ann-Chatrin Linqvist
Department of Anaesthesia, Ostfold Hospital Trust, Moss, Norway.
Faculty of Health, Welfare and Organisation, Ostfold University College, Fredrikstad, Norway.
Eur J Med Res. 2025 Jun 20;30(1):498. doi: 10.1186/s40001-025-02798-8.
Endotracheal intubation may be performed using deep anesthesia, neuromuscular blocks, or the topical application of anesthetics on the vocal cords. The null hypothesis in this study was that there is no difference in hoarseness one hour after extubation between patients receiving neuromuscular blocks versus lidocaine sprayed on the glottis for endotracheal intubation.
A randomized, controlled, double-blinded study was conducted. A total of 114 patients were included. Group I (n = 58) received rocuronium 0.6 mg/kg. Group II (n = 56) received lidocaine spray 4 ml (20 mg/ml) on the vocal cords. The primary outcome measure was hoarseness one hour after extubation. Secondary outcomes were hoarseness at 24 and 48 h after extubation, sore throat at 1, 24, and 48 h after extubation, and intubation and extubation conditions.
There was no statistically significant difference between groups in hoarseness one hour after extubation. At 24 h, Group I had significantly more reported hoarseness (27.6%) and observed hoarseness (1.7%) than Group II (12.5% reported) (p = 0.03). Group II had a significantly sorer throat (21.4%) than Group I (1.7%) (p < 0.001) at one hour. Beyond this, there were no differences between groups.
Even though some differences were observed in hoarseness and sore throat 24 h after extubation, there were few differences between topical lidocaine spray and the use of neuromuscular blocks before intubation for patient-reported and observed outcomes. Consequently, clinicians should choose an approach based on considerations other than those included in this study, such as the need for muscle relaxation or minimizing the number of laryngoscopies. THE STUDY WAS PROSPECTIVELY REGISTERED AT CLINICALTRIALS.GOV : NCT05614609.
气管插管可在深度麻醉、使用神经肌肉阻滞剂或在声带局部应用麻醉剂的情况下进行。本研究的零假设是,接受神经肌肉阻滞剂与在声门上喷洒利多卡因进行气管插管的患者,拔管后1小时的声音嘶哑情况无差异。
进行了一项随机、对照、双盲研究。共纳入114例患者。第一组(n = 58)接受0.6 mg/kg罗库溴铵。第二组(n = 56)在声带上喷洒4 ml(20 mg/ml)利多卡因。主要结局指标是拔管后1小时的声音嘶哑情况。次要结局指标是拔管后24小时和48小时的声音嘶哑情况、拔管后1小时、24小时和48小时的咽痛情况以及插管和拔管条件。
拔管后1小时,两组之间的声音嘶哑情况无统计学显著差异。在24小时时,第一组报告的声音嘶哑(27.6%)和观察到的声音嘶哑(1.7%)明显多于第二组(报告为12.5%)(p = 0.03)。在1小时时,第二组的咽痛(21.4%)明显比第一组(1.7%)更严重(p < 0.001)。除此之外,两组之间没有差异。
尽管在拔管后24小时观察到声音嘶哑和咽痛存在一些差异,但对于患者报告和观察到的结局而言,局部喷洒利多卡因与插管前使用神经肌肉阻滞剂之间几乎没有差异。因此,临床医生应基于本研究未涵盖的其他因素来选择方法,例如对肌肉松弛的需求或尽量减少喉镜检查的次数。该研究已在ClinicalTrials.gov上进行前瞻性注册:NCT05614609。